nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—Cytochrome P450 1A2 Inhibitors—Vemurafenib—melanoma	0.595	0.807	CiPCiCtD
Amiodarone—P-Glycoprotein Inhibitors—Vemurafenib—melanoma	0.142	0.193	CiPCiCtD
Amiodarone—ABCB1—melanoma	0.0382	1	CbGaD
Amiodarone—CYP1A1—Dacarbazine—melanoma	0.0231	0.175	CbGbCtD
Amiodarone—CYP1A2—Carmustine—melanoma	0.017	0.129	CbGbCtD
Amiodarone—CYP1A2—Vemurafenib—melanoma	0.0135	0.102	CbGbCtD
Amiodarone—CYP3A4—Temozolomide—melanoma	0.0129	0.0975	CbGbCtD
Amiodarone—CYP2D6—Vemurafenib—melanoma	0.0111	0.0841	CbGbCtD
Amiodarone—CYP1A2—Dacarbazine—melanoma	0.0103	0.0782	CbGbCtD
Amiodarone—CYP3A7—Docetaxel—melanoma	0.00827	0.0627	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.00827	0.0627	CbGbCtD
Amiodarone—ABCB1—Dactinomycin—melanoma	0.00782	0.0593	CbGbCtD
Amiodarone—CYP3A4—Vemurafenib—melanoma	0.00705	0.0534	CbGbCtD
Amiodarone—CYP3A5—Docetaxel—melanoma	0.0062	0.047	CbGbCtD
Amiodarone—ABCB1—Docetaxel—melanoma	0.00404	0.0306	CbGbCtD
Amiodarone—CYP3A4—Docetaxel—melanoma	0.00242	0.0183	CbGbCtD
Amiodarone—Lucanthone—APEX1—melanoma	0.00178	0.631	CrCbGaD
Amiodarone—Proparacaine—SCN10A—melanoma	0.000343	0.122	CrCbGaD
Amiodarone—Oxybuprocaine—SCN10A—melanoma	0.000314	0.111	CrCbGaD
Amiodarone—Cinchocaine—SCN10A—melanoma	0.000278	0.0986	CrCbGaD
Amiodarone—Skin exfoliation—Docetaxel—melanoma	0.000126	0.00209	CcSEcCtD
Amiodarone—Neuropathy—Docetaxel—melanoma	0.000124	0.00205	CcSEcCtD
Amiodarone—Pneumonia—Dactinomycin—melanoma	0.000123	0.00204	CcSEcCtD
Amiodarone—Pancytopenia—Carmustine—melanoma	0.000122	0.00203	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000121	0.00201	CcSEcCtD
Amiodarone—Neutropenia—Carmustine—melanoma	0.00012	0.00199	CcSEcCtD
Amiodarone—Decreased appetite—Vemurafenib—melanoma	0.00012	0.00199	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Vemurafenib—melanoma	0.000119	0.00198	CcSEcCtD
Amiodarone—Fatigue—Vemurafenib—melanoma	0.000119	0.00198	CcSEcCtD
Amiodarone—Constipation—Vemurafenib—melanoma	0.000118	0.00196	CcSEcCtD
Amiodarone—Pancytopenia—Temozolomide—melanoma	0.000118	0.00196	CcSEcCtD
Amiodarone—Pulmonary oedema—Docetaxel—melanoma	0.000117	0.00194	CcSEcCtD
Amiodarone—Neutropenia—Temozolomide—melanoma	0.000116	0.00193	CcSEcCtD
Amiodarone—Pneumonia—Carmustine—melanoma	0.000115	0.00191	CcSEcCtD
Amiodarone—Erectile dysfunction—Temozolomide—melanoma	0.000114	0.0019	CcSEcCtD
Amiodarone—Agranulocytosis—Dactinomycin—melanoma	0.000114	0.0019	CcSEcCtD
Amiodarone—Photosensitivity reaction—Temozolomide—melanoma	0.000113	0.00188	CcSEcCtD
Amiodarone—Weight increased—Temozolomide—melanoma	0.000113	0.00188	CcSEcCtD
Amiodarone—Renal failure—Carmustine—melanoma	0.000113	0.00187	CcSEcCtD
Amiodarone—Weight decreased—Temozolomide—melanoma	0.000112	0.00186	CcSEcCtD
Amiodarone—Neuropathy peripheral—Carmustine—melanoma	0.000112	0.00186	CcSEcCtD
Amiodarone—Pneumonia—Temozolomide—melanoma	0.000111	0.00185	CcSEcCtD
Amiodarone—Phlebitis—Docetaxel—melanoma	0.000111	0.00184	CcSEcCtD
Amiodarone—Thrombophlebitis—Docetaxel—melanoma	0.00011	0.00183	CcSEcCtD
Amiodarone—Hepatitis—Dactinomycin—melanoma	0.00011	0.00182	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00011	0.00182	CcSEcCtD
Amiodarone—Flushing—Bleomycin—melanoma	0.000109	0.00181	CcSEcCtD
Amiodarone—Body temperature increased—Vemurafenib—melanoma	0.000109	0.00181	CcSEcCtD
Amiodarone—Neuropathy peripheral—Temozolomide—melanoma	0.000109	0.0018	CcSEcCtD
Amiodarone—Hepatic failure—Docetaxel—melanoma	0.000106	0.00176	CcSEcCtD
Amiodarone—Cardiac failure congestive—Docetaxel—melanoma	0.000105	0.00175	CcSEcCtD
Amiodarone—Alopecia—Bleomycin—melanoma	0.000104	0.00173	CcSEcCtD
Amiodarone—Erythema multiforme—Dactinomycin—melanoma	0.000104	0.00172	CcSEcCtD
Amiodarone—Erythema—Bleomycin—melanoma	0.000103	0.0017	CcSEcCtD
Amiodarone—Hallucination—Carmustine—melanoma	0.000102	0.0017	CcSEcCtD
Amiodarone—Hot flush—Docetaxel—melanoma	0.000102	0.0017	CcSEcCtD
Amiodarone—Flushing—Dactinomycin—melanoma	0.000102	0.00169	CcSEcCtD
Amiodarone—Hypersensitivity—Vemurafenib—melanoma	0.000102	0.00169	CcSEcCtD
Amiodarone—Menopausal symptoms—Docetaxel—melanoma	0.000101	0.00168	CcSEcCtD
Amiodarone—Visual disturbance—Docetaxel—melanoma	0.000101	0.00167	CcSEcCtD
Amiodarone—Atrial fibrillation—Docetaxel—melanoma	0.000101	0.00167	CcSEcCtD
Amiodarone—Renal impairment—Docetaxel—melanoma	0.0001	0.00167	CcSEcCtD
Amiodarone—Hepatitis—Temozolomide—melanoma	9.94e-05	0.00165	CcSEcCtD
Amiodarone—Asthenia—Vemurafenib—melanoma	9.92e-05	0.00165	CcSEcCtD
Amiodarone—Visual impairment—Carmustine—melanoma	9.92e-05	0.00165	CcSEcCtD
Amiodarone—Hallucination—Temozolomide—melanoma	9.89e-05	0.00164	CcSEcCtD
Amiodarone—Cardiac failure—Docetaxel—melanoma	9.79e-05	0.00162	CcSEcCtD
Amiodarone—Pruritus—Vemurafenib—melanoma	9.78e-05	0.00162	CcSEcCtD
Amiodarone—Alopecia—Dactinomycin—melanoma	9.71e-05	0.00161	CcSEcCtD
Amiodarone—Visual impairment—Temozolomide—melanoma	9.58e-05	0.00159	CcSEcCtD
Amiodarone—Erythema—Dactinomycin—melanoma	9.57e-05	0.00159	CcSEcCtD
Amiodarone—Flushing—Carmustine—melanoma	9.55e-05	0.00158	CcSEcCtD
Amiodarone—Ill-defined disorder—Bleomycin—melanoma	9.52e-05	0.00158	CcSEcCtD
Amiodarone—Diarrhoea—Vemurafenib—melanoma	9.46e-05	0.00157	CcSEcCtD
Amiodarone—Erythema multiforme—Temozolomide—melanoma	9.4e-05	0.00156	CcSEcCtD
Amiodarone—Tinnitus—Temozolomide—melanoma	9.27e-05	0.00154	CcSEcCtD
Amiodarone—Malaise—Bleomycin—melanoma	9.25e-05	0.00154	CcSEcCtD
Amiodarone—Flushing—Temozolomide—melanoma	9.23e-05	0.00153	CcSEcCtD
Amiodarone—Arrhythmia—Carmustine—melanoma	9.19e-05	0.00152	CcSEcCtD
Amiodarone—Dizziness—Vemurafenib—melanoma	9.14e-05	0.00152	CcSEcCtD
Amiodarone—Alopecia—Carmustine—melanoma	9.09e-05	0.00151	CcSEcCtD
Amiodarone—Ataxia—Docetaxel—melanoma	8.99e-05	0.00149	CcSEcCtD
Amiodarone—Erythema—Carmustine—melanoma	8.96e-05	0.00149	CcSEcCtD
Amiodarone—Cough—Bleomycin—melanoma	8.95e-05	0.00149	CcSEcCtD
Amiodarone—Ill-defined disorder—Dactinomycin—melanoma	8.88e-05	0.00147	CcSEcCtD
Amiodarone—Liver function test abnormal—Docetaxel—melanoma	8.82e-05	0.00146	CcSEcCtD
Amiodarone—Vomiting—Vemurafenib—melanoma	8.79e-05	0.00146	CcSEcCtD
Amiodarone—Alopecia—Temozolomide—melanoma	8.79e-05	0.00146	CcSEcCtD
Amiodarone—Rash—Vemurafenib—melanoma	8.72e-05	0.00145	CcSEcCtD
Amiodarone—Dermatitis—Vemurafenib—melanoma	8.71e-05	0.00144	CcSEcCtD
Amiodarone—Back pain—Carmustine—melanoma	8.66e-05	0.00144	CcSEcCtD
Amiodarone—Headache—Vemurafenib—melanoma	8.66e-05	0.00144	CcSEcCtD
Amiodarone—Erythema—Temozolomide—melanoma	8.66e-05	0.00144	CcSEcCtD
Amiodarone—Discomfort—Bleomycin—melanoma	8.63e-05	0.00143	CcSEcCtD
Amiodarone—Malaise—Dactinomycin—melanoma	8.63e-05	0.00143	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Docetaxel—melanoma	8.61e-05	0.00143	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Docetaxel—melanoma	8.61e-05	0.00143	CcSEcCtD
Amiodarone—Dysgeusia—Temozolomide—melanoma	8.48e-05	0.00141	CcSEcCtD
Amiodarone—Confusional state—Bleomycin—melanoma	8.44e-05	0.0014	CcSEcCtD
Amiodarone—Vision blurred—Carmustine—melanoma	8.44e-05	0.0014	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Docetaxel—melanoma	8.43e-05	0.0014	CcSEcCtD
Amiodarone—Tremor—Carmustine—melanoma	8.39e-05	0.00139	CcSEcCtD
Amiodarone—Oedema—Bleomycin—melanoma	8.37e-05	0.00139	CcSEcCtD
Amiodarone—Anaphylactic shock—Bleomycin—melanoma	8.37e-05	0.00139	CcSEcCtD
Amiodarone—Back pain—Temozolomide—melanoma	8.37e-05	0.00139	CcSEcCtD
Amiodarone—Infection—Bleomycin—melanoma	8.32e-05	0.00138	CcSEcCtD
Amiodarone—Agitation—Carmustine—melanoma	8.23e-05	0.00137	CcSEcCtD
Amiodarone—Nausea—Vemurafenib—melanoma	8.21e-05	0.00136	CcSEcCtD
Amiodarone—Thrombocytopenia—Bleomycin—melanoma	8.2e-05	0.00136	CcSEcCtD
Amiodarone—Vision blurred—Temozolomide—melanoma	8.16e-05	0.00135	CcSEcCtD
Amiodarone—Bronchospasm—Docetaxel—melanoma	8.13e-05	0.00135	CcSEcCtD
Amiodarone—Tremor—Temozolomide—melanoma	8.11e-05	0.00135	CcSEcCtD
Amiodarone—Discomfort—Dactinomycin—melanoma	8.05e-05	0.00134	CcSEcCtD
Amiodarone—Angina pectoris—Docetaxel—melanoma	8.05e-05	0.00134	CcSEcCtD
Amiodarone—Ill-defined disorder—Temozolomide—melanoma	8.03e-05	0.00133	CcSEcCtD
Amiodarone—Anorexia—Bleomycin—melanoma	7.98e-05	0.00132	CcSEcCtD
Amiodarone—Agitation—Temozolomide—melanoma	7.95e-05	0.00132	CcSEcCtD
Amiodarone—Angioedema—Temozolomide—melanoma	7.91e-05	0.00131	CcSEcCtD
Amiodarone—Pancytopenia—Docetaxel—melanoma	7.85e-05	0.0013	CcSEcCtD
Amiodarone—Hypotension—Bleomycin—melanoma	7.83e-05	0.0013	CcSEcCtD
Amiodarone—Oedema—Dactinomycin—melanoma	7.81e-05	0.0013	CcSEcCtD
Amiodarone—Malaise—Temozolomide—melanoma	7.81e-05	0.00129	CcSEcCtD
Amiodarone—Vertigo—Temozolomide—melanoma	7.78e-05	0.00129	CcSEcCtD
Amiodarone—Infection—Dactinomycin—melanoma	7.76e-05	0.00129	CcSEcCtD
Amiodarone—Neutropenia—Docetaxel—melanoma	7.73e-05	0.00128	CcSEcCtD
Amiodarone—Thrombocytopenia—Dactinomycin—melanoma	7.65e-05	0.00127	CcSEcCtD
Amiodarone—Anxiety—Carmustine—melanoma	7.6e-05	0.00126	CcSEcCtD
Amiodarone—Cough—Temozolomide—melanoma	7.55e-05	0.00125	CcSEcCtD
Amiodarone—Paraesthesia—Bleomycin—melanoma	7.52e-05	0.00125	CcSEcCtD
Amiodarone—Weight increased—Docetaxel—melanoma	7.52e-05	0.00125	CcSEcCtD
Amiodarone—Weight decreased—Docetaxel—melanoma	7.47e-05	0.00124	CcSEcCtD
Amiodarone—Dyspnoea—Bleomycin—melanoma	7.47e-05	0.00124	CcSEcCtD
Amiodarone—Anorexia—Dactinomycin—melanoma	7.45e-05	0.00124	CcSEcCtD
Amiodarone—Pneumonia—Docetaxel—melanoma	7.41e-05	0.00123	CcSEcCtD
Amiodarone—Confusional state—Carmustine—melanoma	7.37e-05	0.00122	CcSEcCtD
Amiodarone—Anxiety—Temozolomide—melanoma	7.34e-05	0.00122	CcSEcCtD
Amiodarone—Oedema—Carmustine—melanoma	7.31e-05	0.00121	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Docetaxel—melanoma	7.3e-05	0.00121	CcSEcCtD
Amiodarone—Discomfort—Temozolomide—melanoma	7.28e-05	0.00121	CcSEcCtD
Amiodarone—Decreased appetite—Bleomycin—melanoma	7.28e-05	0.00121	CcSEcCtD
Amiodarone—Infection—Carmustine—melanoma	7.26e-05	0.0012	CcSEcCtD
Amiodarone—Renal failure—Docetaxel—melanoma	7.24e-05	0.0012	CcSEcCtD
Amiodarone—Neuropathy peripheral—Docetaxel—melanoma	7.22e-05	0.0012	CcSEcCtD
Amiodarone—Dry mouth—Temozolomide—melanoma	7.21e-05	0.0012	CcSEcCtD
Amiodarone—Jaundice—Docetaxel—melanoma	7.18e-05	0.00119	CcSEcCtD
Amiodarone—Pain—Bleomycin—melanoma	7.16e-05	0.00119	CcSEcCtD
Amiodarone—Thrombocytopenia—Carmustine—melanoma	7.16e-05	0.00119	CcSEcCtD
Amiodarone—Tachycardia—Carmustine—melanoma	7.13e-05	0.00118	CcSEcCtD
Amiodarone—Confusional state—Temozolomide—melanoma	7.12e-05	0.00118	CcSEcCtD
Amiodarone—Anaphylactic shock—Temozolomide—melanoma	7.06e-05	0.00117	CcSEcCtD
Amiodarone—Oedema—Temozolomide—melanoma	7.06e-05	0.00117	CcSEcCtD
Amiodarone—Infection—Temozolomide—melanoma	7.02e-05	0.00116	CcSEcCtD
Amiodarone—Anorexia—Carmustine—melanoma	6.97e-05	0.00116	CcSEcCtD
Amiodarone—Thrombocytopenia—Temozolomide—melanoma	6.92e-05	0.00115	CcSEcCtD
Amiodarone—Feeling abnormal—Bleomycin—melanoma	6.9e-05	0.00114	CcSEcCtD
Amiodarone—Agranulocytosis—Docetaxel—melanoma	6.87e-05	0.00114	CcSEcCtD
Amiodarone—Skin disorder—Temozolomide—melanoma	6.86e-05	0.00114	CcSEcCtD
Amiodarone—Hypotension—Carmustine—melanoma	6.83e-05	0.00113	CcSEcCtD
Amiodarone—Hyperhidrosis—Temozolomide—melanoma	6.83e-05	0.00113	CcSEcCtD
Amiodarone—Decreased appetite—Dactinomycin—melanoma	6.79e-05	0.00113	CcSEcCtD
Amiodarone—Fatigue—Dactinomycin—melanoma	6.73e-05	0.00112	CcSEcCtD
Amiodarone—Anorexia—Temozolomide—melanoma	6.73e-05	0.00112	CcSEcCtD
Amiodarone—Pain—Dactinomycin—melanoma	6.68e-05	0.00111	CcSEcCtD
Amiodarone—Urticaria—Bleomycin—melanoma	6.65e-05	0.0011	CcSEcCtD
Amiodarone—Body temperature increased—Bleomycin—melanoma	6.62e-05	0.0011	CcSEcCtD
Amiodarone—Hepatitis—Docetaxel—melanoma	6.61e-05	0.0011	CcSEcCtD
Amiodarone—Insomnia—Carmustine—melanoma	6.61e-05	0.0011	CcSEcCtD
Amiodarone—Paraesthesia—Carmustine—melanoma	6.56e-05	0.00109	CcSEcCtD
Amiodarone—Dyspnoea—Carmustine—melanoma	6.52e-05	0.00108	CcSEcCtD
Amiodarone—Feeling abnormal—Dactinomycin—melanoma	6.44e-05	0.00107	CcSEcCtD
Amiodarone—Insomnia—Temozolomide—melanoma	6.39e-05	0.00106	CcSEcCtD
Amiodarone—Gastrointestinal pain—Dactinomycin—melanoma	6.39e-05	0.00106	CcSEcCtD
Amiodarone—Visual impairment—Docetaxel—melanoma	6.37e-05	0.00106	CcSEcCtD
Amiodarone—Decreased appetite—Carmustine—melanoma	6.35e-05	0.00105	CcSEcCtD
Amiodarone—Paraesthesia—Temozolomide—melanoma	6.34e-05	0.00105	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Carmustine—melanoma	6.31e-05	0.00105	CcSEcCtD
Amiodarone—Dyspnoea—Temozolomide—melanoma	6.3e-05	0.00104	CcSEcCtD
Amiodarone—Erythema multiforme—Docetaxel—melanoma	6.25e-05	0.00104	CcSEcCtD
Amiodarone—Constipation—Carmustine—melanoma	6.25e-05	0.00104	CcSEcCtD
Amiodarone—Pain—Carmustine—melanoma	6.25e-05	0.00104	CcSEcCtD
Amiodarone—Dyspepsia—Temozolomide—melanoma	6.22e-05	0.00103	CcSEcCtD
Amiodarone—Body temperature increased—Dactinomycin—melanoma	6.17e-05	0.00102	CcSEcCtD
Amiodarone—Abdominal pain—Dactinomycin—melanoma	6.17e-05	0.00102	CcSEcCtD
Amiodarone—Hypersensitivity—Bleomycin—melanoma	6.17e-05	0.00102	CcSEcCtD
Amiodarone—Decreased appetite—Temozolomide—melanoma	6.14e-05	0.00102	CcSEcCtD
Amiodarone—Flushing—Docetaxel—melanoma	6.14e-05	0.00102	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Temozolomide—melanoma	6.1e-05	0.00101	CcSEcCtD
Amiodarone—Fatigue—Temozolomide—melanoma	6.09e-05	0.00101	CcSEcCtD
Amiodarone—Pain—Temozolomide—melanoma	6.04e-05	0.001	CcSEcCtD
Amiodarone—Constipation—Temozolomide—melanoma	6.04e-05	0.001	CcSEcCtD
Amiodarone—Feeling abnormal—Carmustine—melanoma	6.02e-05	0.000999	CcSEcCtD
Amiodarone—Asthenia—Bleomycin—melanoma	6.01e-05	0.000997	CcSEcCtD
Amiodarone—Gastrointestinal pain—Carmustine—melanoma	5.98e-05	0.000992	CcSEcCtD
Amiodarone—Pruritus—Bleomycin—melanoma	5.93e-05	0.000983	CcSEcCtD
Amiodarone—Arrhythmia—Docetaxel—melanoma	5.91e-05	0.00098	CcSEcCtD
Amiodarone—Alopecia—Docetaxel—melanoma	5.84e-05	0.000969	CcSEcCtD
Amiodarone—Feeling abnormal—Temozolomide—melanoma	5.82e-05	0.000966	CcSEcCtD
Amiodarone—Abdominal pain—Carmustine—melanoma	5.78e-05	0.000959	CcSEcCtD
Amiodarone—Body temperature increased—Carmustine—melanoma	5.78e-05	0.000959	CcSEcCtD
Amiodarone—Gastrointestinal pain—Temozolomide—melanoma	5.78e-05	0.000958	CcSEcCtD
Amiodarone—Erythema—Docetaxel—melanoma	5.76e-05	0.000955	CcSEcCtD
Amiodarone—Hypersensitivity—Dactinomycin—melanoma	5.75e-05	0.000955	CcSEcCtD
Amiodarone—Dysgeusia—Docetaxel—melanoma	5.64e-05	0.000935	CcSEcCtD
Amiodarone—Urticaria—Temozolomide—melanoma	5.61e-05	0.000931	CcSEcCtD
Amiodarone—Asthenia—Dactinomycin—melanoma	5.6e-05	0.00093	CcSEcCtD
Amiodarone—Abdominal pain—Temozolomide—melanoma	5.58e-05	0.000926	CcSEcCtD
Amiodarone—Body temperature increased—Temozolomide—melanoma	5.58e-05	0.000926	CcSEcCtD
Amiodarone—Back pain—Docetaxel—melanoma	5.57e-05	0.000924	CcSEcCtD
Amiodarone—Dronedarone—ALB—melanoma	5.53e-05	0.0196	CrCbGaD
Amiodarone—Hypersensitivity—Carmustine—melanoma	5.39e-05	0.000894	CcSEcCtD
Amiodarone—Diarrhoea—Dactinomycin—melanoma	5.34e-05	0.000887	CcSEcCtD
Amiodarone—Vomiting—Bleomycin—melanoma	5.32e-05	0.000883	CcSEcCtD
Amiodarone—Rash—Bleomycin—melanoma	5.28e-05	0.000876	CcSEcCtD
Amiodarone—Dermatitis—Bleomycin—melanoma	5.28e-05	0.000875	CcSEcCtD
Amiodarone—Dronedarone—ABCB1—melanoma	5.27e-05	0.0187	CrCbGaD
Amiodarone—Asthenia—Carmustine—melanoma	5.25e-05	0.00087	CcSEcCtD
Amiodarone—Hypersensitivity—Temozolomide—melanoma	5.2e-05	0.000863	CcSEcCtD
Amiodarone—Asthenia—Temozolomide—melanoma	5.07e-05	0.000841	CcSEcCtD
Amiodarone—Cough—Docetaxel—melanoma	5.02e-05	0.000833	CcSEcCtD
Amiodarone—Diarrhoea—Carmustine—melanoma	5e-05	0.00083	CcSEcCtD
Amiodarone—Pruritus—Temozolomide—melanoma	5e-05	0.000829	CcSEcCtD
Amiodarone—Nausea—Bleomycin—melanoma	4.97e-05	0.000825	CcSEcCtD
Amiodarone—Vomiting—Dactinomycin—melanoma	4.97e-05	0.000824	CcSEcCtD
Amiodarone—Rash—Dactinomycin—melanoma	4.92e-05	0.000817	CcSEcCtD
Amiodarone—Dizziness—Carmustine—melanoma	4.83e-05	0.000802	CcSEcCtD
Amiodarone—Diarrhoea—Temozolomide—melanoma	4.83e-05	0.000802	CcSEcCtD
Amiodarone—Dry mouth—Docetaxel—melanoma	4.79e-05	0.000795	CcSEcCtD
Amiodarone—Confusional state—Docetaxel—melanoma	4.74e-05	0.000786	CcSEcCtD
Amiodarone—Anaphylactic shock—Docetaxel—melanoma	4.7e-05	0.000779	CcSEcCtD
Amiodarone—Oedema—Docetaxel—melanoma	4.7e-05	0.000779	CcSEcCtD
Amiodarone—Dizziness—Temozolomide—melanoma	4.67e-05	0.000775	CcSEcCtD
Amiodarone—Infection—Docetaxel—melanoma	4.67e-05	0.000774	CcSEcCtD
Amiodarone—Vomiting—Carmustine—melanoma	4.65e-05	0.000771	CcSEcCtD
Amiodarone—Nausea—Dactinomycin—melanoma	4.64e-05	0.00077	CcSEcCtD
Amiodarone—Shock—Docetaxel—melanoma	4.62e-05	0.000767	CcSEcCtD
Amiodarone—Rash—Carmustine—melanoma	4.61e-05	0.000765	CcSEcCtD
Amiodarone—Dermatitis—Carmustine—melanoma	4.61e-05	0.000764	CcSEcCtD
Amiodarone—Thrombocytopenia—Docetaxel—melanoma	4.6e-05	0.000763	CcSEcCtD
Amiodarone—Tachycardia—Docetaxel—melanoma	4.59e-05	0.000761	CcSEcCtD
Amiodarone—Headache—Carmustine—melanoma	4.58e-05	0.00076	CcSEcCtD
Amiodarone—Skin disorder—Docetaxel—melanoma	4.56e-05	0.000757	CcSEcCtD
Amiodarone—Vomiting—Temozolomide—melanoma	4.49e-05	0.000745	CcSEcCtD
Amiodarone—Anorexia—Docetaxel—melanoma	4.48e-05	0.000743	CcSEcCtD
Amiodarone—Rash—Temozolomide—melanoma	4.45e-05	0.000739	CcSEcCtD
Amiodarone—Dermatitis—Temozolomide—melanoma	4.45e-05	0.000738	CcSEcCtD
Amiodarone—Headache—Temozolomide—melanoma	4.43e-05	0.000734	CcSEcCtD
Amiodarone—Hypotension—Docetaxel—melanoma	4.39e-05	0.000728	CcSEcCtD
Amiodarone—Nausea—Carmustine—melanoma	4.34e-05	0.00072	CcSEcCtD
Amiodarone—Insomnia—Docetaxel—melanoma	4.25e-05	0.000705	CcSEcCtD
Amiodarone—Paraesthesia—Docetaxel—melanoma	4.22e-05	0.0007	CcSEcCtD
Amiodarone—Nausea—Temozolomide—melanoma	4.2e-05	0.000696	CcSEcCtD
Amiodarone—Dyspnoea—Docetaxel—melanoma	4.19e-05	0.000695	CcSEcCtD
Amiodarone—Dyspepsia—Docetaxel—melanoma	4.14e-05	0.000686	CcSEcCtD
Amiodarone—Decreased appetite—Docetaxel—melanoma	4.08e-05	0.000678	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Docetaxel—melanoma	4.06e-05	0.000673	CcSEcCtD
Amiodarone—Fatigue—Docetaxel—melanoma	4.05e-05	0.000672	CcSEcCtD
Amiodarone—Constipation—Docetaxel—melanoma	4.02e-05	0.000666	CcSEcCtD
Amiodarone—Pain—Docetaxel—melanoma	4.02e-05	0.000666	CcSEcCtD
Amiodarone—Feeling abnormal—Docetaxel—melanoma	3.87e-05	0.000642	CcSEcCtD
Amiodarone—Gastrointestinal pain—Docetaxel—melanoma	3.84e-05	0.000637	CcSEcCtD
Amiodarone—Abdominal pain—Docetaxel—melanoma	3.71e-05	0.000616	CcSEcCtD
Amiodarone—Body temperature increased—Docetaxel—melanoma	3.71e-05	0.000616	CcSEcCtD
Amiodarone—Hypersensitivity—Docetaxel—melanoma	3.46e-05	0.000574	CcSEcCtD
Amiodarone—Asthenia—Docetaxel—melanoma	3.37e-05	0.000559	CcSEcCtD
Amiodarone—Pruritus—Docetaxel—melanoma	3.32e-05	0.000551	CcSEcCtD
Amiodarone—Diarrhoea—Docetaxel—melanoma	3.21e-05	0.000533	CcSEcCtD
Amiodarone—Dizziness—Docetaxel—melanoma	3.11e-05	0.000515	CcSEcCtD
Amiodarone—Vomiting—Docetaxel—melanoma	2.99e-05	0.000496	CcSEcCtD
Amiodarone—Rash—Docetaxel—melanoma	2.96e-05	0.000491	CcSEcCtD
Amiodarone—Dermatitis—Docetaxel—melanoma	2.96e-05	0.000491	CcSEcCtD
Amiodarone—Headache—Docetaxel—melanoma	2.94e-05	0.000488	CcSEcCtD
Amiodarone—Nausea—Docetaxel—melanoma	2.79e-05	0.000463	CcSEcCtD
Amiodarone—CYP3A4—Metabolism—BSG—melanoma	2.21e-06	7.49e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.21e-06	7.49e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.19e-06	7.42e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GNA11—melanoma	2.17e-06	7.34e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CYP1B1—melanoma	2.16e-06	7.33e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL2—melanoma	2.14e-06	7.26e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GPAM—melanoma	2.14e-06	7.25e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TERT—melanoma	2.14e-06	7.24e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—RAC1—melanoma	2.13e-06	7.22e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—FASN—melanoma	2.12e-06	7.18e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—VCAN—melanoma	2.12e-06	7.18e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GNA11—melanoma	2.11e-06	7.16e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP17A1—melanoma	2.11e-06	7.15e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP17A1—melanoma	2.09e-06	7.09e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—SLC5A5—melanoma	2.09e-06	7.07e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.08e-06	7.06e-05	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	2.07e-06	7.02e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—FASN—melanoma	2.07e-06	7.01e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.06e-06	6.99e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ABCB1—melanoma	2.06e-06	6.97e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CG—melanoma	2.05e-06	6.95e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HIF1A—melanoma	2.04e-06	6.92e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	2.04e-06	6.9e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—SLC5A5—melanoma	2.04e-06	6.9e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CD44—melanoma	2.01e-06	6.82e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GNAQ—melanoma	2.01e-06	6.82e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.01e-06	6.79e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GNA11—melanoma	1.99e-06	6.75e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PPARG—melanoma	1.98e-06	6.71e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GNA11—melanoma	1.98e-06	6.69e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.97e-06	6.68e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CD44—melanoma	1.97e-06	6.66e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GNAQ—melanoma	1.97e-06	6.66e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.95e-06	6.62e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KDR—melanoma	1.95e-06	6.62e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—FASN—melanoma	1.95e-06	6.61e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ABCB1—melanoma	1.94e-06	6.58e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.94e-06	6.56e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—FASN—melanoma	1.93e-06	6.55e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CYP1B1—melanoma	1.93e-06	6.54e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—SLC5A5—melanoma	1.92e-06	6.5e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.91e-06	6.47e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—SLC5A5—melanoma	1.9e-06	6.44e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PRKCA—melanoma	1.89e-06	6.41e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP1B1—melanoma	1.89e-06	6.39e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—FN1—melanoma	1.88e-06	6.37e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CG—melanoma	1.88e-06	6.37e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ERCC2—melanoma	1.88e-06	6.36e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GNAQ—melanoma	1.85e-06	6.28e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CD44—melanoma	1.85e-06	6.28e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NOTCH1—melanoma	1.84e-06	6.23e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GNAQ—melanoma	1.84e-06	6.22e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CD44—melanoma	1.84e-06	6.22e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PLA2G6—melanoma	1.82e-06	6.17e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PPARG—melanoma	1.81e-06	6.15e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CD—melanoma	1.8e-06	6.11e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CD80—melanoma	1.8e-06	6.11e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—APC—melanoma	1.8e-06	6.1e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KIT—melanoma	1.8e-06	6.1e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CG—melanoma	1.8e-06	6.1e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—NRAS—melanoma	1.8e-06	6.1e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.8e-06	6.09e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PRKCA—melanoma	1.79e-06	6.06e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP17A1—melanoma	1.79e-06	6.06e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.78e-06	6.04e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ABCB1—melanoma	1.78e-06	6.04e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—ALB—melanoma	1.78e-06	6.03e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EGF—melanoma	1.78e-06	6.03e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP1B1—melanoma	1.78e-06	6.02e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ERCC2—melanoma	1.77e-06	6.01e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.76e-06	5.97e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP1B1—melanoma	1.76e-06	5.97e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.74e-06	5.9e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—MAPK3—melanoma	1.72e-06	5.84e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.7e-06	5.77e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—BRAF—melanoma	1.69e-06	5.73e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GNA11—melanoma	1.69e-06	5.72e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CD—melanoma	1.65e-06	5.6e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—FASN—melanoma	1.65e-06	5.6e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IGF1—melanoma	1.65e-06	5.58e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—MAPK1—melanoma	1.64e-06	5.56e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PRKCA—melanoma	1.64e-06	5.55e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—EGFR—melanoma	1.64e-06	5.55e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—VCAN—melanoma	1.64e-06	5.54e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ALB—melanoma	1.63e-06	5.53e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ERCC2—melanoma	1.63e-06	5.51e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SLC5A5—melanoma	1.63e-06	5.51e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MAP2K1—melanoma	1.59e-06	5.4e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ABCB1—melanoma	1.59e-06	5.39e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CD—melanoma	1.58e-06	5.36e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CB—melanoma	1.57e-06	5.32e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GNAQ—melanoma	1.57e-06	5.32e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CD44—melanoma	1.57e-06	5.32e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—PIK3CA—melanoma	1.57e-06	5.31e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTGS2—melanoma	1.56e-06	5.28e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.55e-06	5.26e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—KRAS—melanoma	1.55e-06	5.25e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.54e-06	5.21e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.52e-06	5.16e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—FGF2—melanoma	1.51e-06	5.13e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP1B1—melanoma	1.5e-06	5.1e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CG—melanoma	1.48e-06	5.02e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.47e-06	4.98e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PRKCA—melanoma	1.46e-06	4.96e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ABCB1—melanoma	1.46e-06	4.96e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ERCC2—melanoma	1.45e-06	4.92e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ABCB1—melanoma	1.45e-06	4.91e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CB—melanoma	1.44e-06	4.88e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PPARG—melanoma	1.43e-06	4.85e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PRKCA—melanoma	1.43e-06	4.84e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTGS2—melanoma	1.43e-06	4.84e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PIK3CA—melanoma	1.42e-06	4.82e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MDM2—melanoma	1.42e-06	4.8e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ERCC2—melanoma	1.42e-06	4.8e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CG—melanoma	1.4e-06	4.75e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ERBB2—melanoma	1.4e-06	4.73e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP17A1—melanoma	1.38e-06	4.67e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CB—melanoma	1.38e-06	4.67e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTEN—melanoma	1.36e-06	4.6e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PPARG—melanoma	1.35e-06	4.58e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.35e-06	4.56e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PRKCA—melanoma	1.35e-06	4.56e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ERCC2—melanoma	1.34e-06	4.52e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PRKCA—melanoma	1.33e-06	4.52e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.33e-06	4.5e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CXCL8—melanoma	1.33e-06	4.49e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ERCC2—melanoma	1.32e-06	4.48e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—HRAS—melanoma	1.32e-06	4.46e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CD—melanoma	1.3e-06	4.42e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GNA11—melanoma	1.3e-06	4.41e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDKN1B—melanoma	1.29e-06	4.38e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ALB—melanoma	1.29e-06	4.36e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CG—melanoma	1.28e-06	4.35e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AKT1—melanoma	1.28e-06	4.34e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—FASN—melanoma	1.28e-06	4.32e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CASP3—melanoma	1.27e-06	4.3e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL2—melanoma	1.27e-06	4.29e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL6—melanoma	1.26e-06	4.27e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC5A5—melanoma	1.25e-06	4.25e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTEN—melanoma	1.25e-06	4.22e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PPARG—melanoma	1.24e-06	4.2e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ABCB1—melanoma	1.24e-06	4.2e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCND1—melanoma	1.23e-06	4.18e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CD—melanoma	1.23e-06	4.17e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CTNNB1—melanoma	1.22e-06	4.14e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ALB—melanoma	1.22e-06	4.12e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GNAQ—melanoma	1.21e-06	4.1e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CD44—melanoma	1.21e-06	4.1e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.2e-06	4.07e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MMP9—melanoma	1.2e-06	4.06e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDKN1A—melanoma	1.19e-06	4.05e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTEN—melanoma	1.19e-06	4.04e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NFKB1—melanoma	1.19e-06	4.02e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AKT1—melanoma	1.16e-06	3.94e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP1B1—melanoma	1.16e-06	3.93e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CG—melanoma	1.15e-06	3.88e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PRKCA—melanoma	1.14e-06	3.86e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CB—melanoma	1.14e-06	3.85e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ERCC2—melanoma	1.13e-06	3.83e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CD—melanoma	1.13e-06	3.82e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTGS2—melanoma	1.13e-06	3.81e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CG—melanoma	1.12e-06	3.79e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ALB—melanoma	1.11e-06	3.78e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PPARG—melanoma	1.11e-06	3.75e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.1e-06	3.71e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PPARG—melanoma	1.08e-06	3.66e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VEGFA—melanoma	1.08e-06	3.65e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CB—melanoma	1.07e-06	3.64e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—STAT3—melanoma	1.07e-06	3.61e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTGS2—melanoma	1.06e-06	3.6e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NRAS—melanoma	1.06e-06	3.6e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CG—melanoma	1.05e-06	3.57e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CG—melanoma	1.05e-06	3.54e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MAPK3—melanoma	1.02e-06	3.45e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PPARG—melanoma	1.02e-06	3.45e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PPARG—melanoma	1.01e-06	3.42e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CD—melanoma	1.01e-06	3.41e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ALB—melanoma	9.95e-07	3.37e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MYC—melanoma	9.9e-07	3.35e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CB—melanoma	9.84e-07	3.33e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CD—melanoma	9.84e-07	3.33e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTEN—melanoma	9.82e-07	3.33e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTGS2—melanoma	9.75e-07	3.3e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ALB—melanoma	9.71e-07	3.29e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MAPK1—melanoma	9.69e-07	3.28e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EGFR—melanoma	9.69e-07	3.28e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CA—melanoma	9.58e-07	3.25e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ABCB1—melanoma	9.56e-07	3.24e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.37e-07	3.17e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTEN—melanoma	9.28e-07	3.14e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CD—melanoma	9.27e-07	3.14e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CD—melanoma	9.19e-07	3.11e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KRAS—melanoma	9.15e-07	3.1e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ALB—melanoma	9.15e-07	3.1e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ALB—melanoma	9.07e-07	3.07e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CG—melanoma	8.93e-07	3.03e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PRKCA—melanoma	8.8e-07	2.98e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CB—melanoma	8.78e-07	2.98e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CA—melanoma	8.78e-07	2.98e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ERCC2—melanoma	8.73e-07	2.96e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTGS2—melanoma	8.7e-07	2.95e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PPARG—melanoma	8.62e-07	2.92e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CB—melanoma	8.57e-07	2.9e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTEN—melanoma	8.5e-07	2.88e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTGS2—melanoma	8.5e-07	2.88e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CA—melanoma	8.41e-07	2.85e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—melanoma	8.13e-07	2.76e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CB—melanoma	8.08e-07	2.74e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CB—melanoma	8.01e-07	2.71e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTGS2—melanoma	8.01e-07	2.71e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTGS2—melanoma	7.94e-07	2.69e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CD—melanoma	7.85e-07	2.66e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—AKT1—melanoma	7.83e-07	2.65e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HRAS—melanoma	7.78e-07	2.63e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ALB—melanoma	7.75e-07	2.63e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTEN—melanoma	7.59e-07	2.57e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL6—melanoma	7.44e-07	2.52e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTEN—melanoma	7.41e-07	2.51e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—AKT1—melanoma	7.18e-07	2.43e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTEN—melanoma	6.98e-07	2.37e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CA—melanoma	6.93e-07	2.35e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTEN—melanoma	6.92e-07	2.34e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CG—melanoma	6.89e-07	2.34e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AKT1—melanoma	6.87e-07	2.33e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CB—melanoma	6.84e-07	2.32e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTGS2—melanoma	6.78e-07	2.3e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PPARG—melanoma	6.65e-07	2.25e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CA—melanoma	6.54e-07	2.22e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CD—melanoma	6.06e-07	2.05e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CA—melanoma	6e-07	2.03e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALB—melanoma	5.98e-07	2.03e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTEN—melanoma	5.91e-07	2e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AKT1—melanoma	5.66e-07	1.92e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CA—melanoma	5.36e-07	1.81e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AKT1—melanoma	5.35e-07	1.81e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CB—melanoma	5.28e-07	1.79e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTGS2—melanoma	5.23e-07	1.77e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CA—melanoma	5.23e-07	1.77e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CA—melanoma	4.93e-07	1.67e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AKT1—melanoma	4.9e-07	1.66e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CA—melanoma	4.88e-07	1.65e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTEN—melanoma	4.56e-07	1.55e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AKT1—melanoma	4.37e-07	1.48e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AKT1—melanoma	4.27e-07	1.45e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CA—melanoma	4.17e-07	1.41e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AKT1—melanoma	4.02e-07	1.36e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AKT1—melanoma	3.99e-07	1.35e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AKT1—melanoma	3.41e-07	1.15e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CA—melanoma	3.22e-07	1.09e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AKT1—melanoma	2.63e-07	8.91e-06	CbGpPWpGaD
